Global Oncology Academy

Exploring the Treatment Landscape for Triple-Negative Breast Cancer

ReachMD Healthcare Image

Find out what treatment options are available for your patients with triple-negative breast cancer.

  • Overview

    Triple-negative breast cancer can be a challenging battle for patients, especially when it comes to treatment. And that's why the ASCENT trial dove into the treatment landscape for these patients. Lead investigator of this trial, Dr. Aditya Bardia, sits down with Dr. Pavani Chalasani for an inside look at this trial and what it means for patients with triple-negative breast cancer.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free